Sklawer Andrew D - Insider Non-Derivative Transactions at Fresh Tracks Therapeutics, Inc. (FRTX) - (SEC)

Updated on December 12, 2024.

According to recent SEC insider information filed on Oct 2, 2023, Sklawer Andrew D's relationship to Fresh Tracks Therapeutics, Inc. (FRTX) is Officer (President and CEO), and currently has 60,102 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other FRTX insiders.

Data Source: SEC.
Sklawer Andrew D - Insider Non-Derivative Transactions of FRTX Common Stock
Sklawer Andrew D - Insider Non-Derivative Transactions at FRTX
Items per page:
0 of 0
Date Transaction No. of Shares Price Per Share Shares Owned After Transactions
Oct 3, 2023 F -- (Common Stock) 20833 0.98 39269
Oct 3, 2023 M -- (Common Stock) 55000 0 60102